Implantable cardioverter defibrillators (ICDs) have a long history and have progressed
significantly since the 1980s. They have become an essential part of the prevention of …

Aims A long-detection interval (LDI)(30/40 intervals) has been proved to be superior to a
standard-detection interval (SDI)(18/24 intervals) in terms of reducing unnecessary …

Aims Anti-tachycardia pacing (ATP) is a reliable electrotherapy to painlessly terminate
ventricular tachycardia (VT). However, ATP is often ineffective, particularly for fast VTs. The …

Introduction Antitachycardia pacing (ATP) is used to terminate ventricular tachycardia (VT)
by delivering rapid, low energy pacing to the right ventricle (RV). Unfortunately, ATP is not …

Background In hypertrophic cardiomyopathy (HCM) patients implanted with an implantable
cardioverter defibrillator (ICD), clinical outcomes of antitachycardia pacing (ATP) have been …

Antitachycardia pacing (ATP) strategies represent safe, effective, and painless therapy for
ventricular tachyarrhythmias, with a large body of clinical evidence supporting their routine …

BACKGROUND: Antitachycardia pacing (ATP) fails to terminate 5% to 25% of ventricular
tachycardias (VTs) occurring in implantable cardioverter-defibrillator patients. We …

Introduction The prognostic impact of nonsustained ventricular tachycardia (NSVT)
morphology has never been explored in hypertrophic cardiomyopathy (HCM). In a single …

Morphology of Far‐Field Electrograms and ATP Effectiveness Introduction Fast ventricular
tachycardias (FVT) are less likely to be terminated by antitachycardia pacing (ATP). No …

ICDs and Signal Analyses Introduction Antitachycardia pacing (ATP), a quick, painless, and
effective therapy available in implantable cardioverter‐defibrillators (ICDs), can terminate …